Saladaga, Eden Rose .
HRN: 04-86-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/22/2026
CEFUROXIME 500MG (TAB)
07/22/2026
07/29/2026
PO
500mg
BID
Thickly MSAF
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: